01
Cash & equivalents decreased 71.3%
Cash & equivalents changed -71.3% from the comparable as-filed period.
$86.8M→$24.9MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTPLIANT THERAPEUTICS, INC.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -71.3% from the comparable as-filed period.
Debt changed -100.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +48.3% from the comparable as-filed period.
Operating income changed +47.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
PLRX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001746473-26-000115SEC ↗10-QAug 11, 2026Period Jun 30, 20260001746473-26-000113SEC ↗4Jul 13, 2026Period Jul 9, 20260001737329-26-000013SEC ↗4Jul 13, 2026Period Jul 9, 20260001867426-26-000004SEC ↗8-KJul 13, 2026Period Jul 9, 20260001746473-26-000107SEC ↗4Jun 12, 2026Period Jun 11, 20260001746473-26-000104SEC ↗4Jun 12, 2026Period Jun 11, 20260001746473-26-000103SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 9, 2026Filed Jul 13, 2026 | Iannone RobertDirector | Grant Or AwardDirect | 60,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -48.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed -34.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001746473-26-000102